Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

Historical Holders from Q3 2021 to Q3 2025

Symbol
ABOS on Nasdaq
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
60.7M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
35.7M
Holdings value
$61.1M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
68
Number of buys
22
Number of sells
-39
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 24.8% $16.5M 15M RA Capital Management, L.P. 27 Mar 2025
Sands Capital Alternatives, LLC 5.6% $3.86M 3.42M Sands Capital Alternatives, LLC 30 Jun 2025
FRANKLIN RESOURCES INC 3.8% $3.94M 2.31M Franklin Resources, Inc. 30 Sep 2025

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 35.7M $61.1M -$2.86M $1.71 68
2025 Q2 37.6M $43.6M -$2.1M $1.16 69
2025 Q1 39.4M $43.3M -$3.63M $1.10 79
2024 Q4 42.5M $73.1M -$2.31M $1.72 78
2024 Q3 43.6M $108M -$213K $2.48 72
2024 Q2 43.6M $105M -$2.32M $2.42 81
2024 Q1 43.4M $176M +$20M $4.05 78
2023 Q4 38.4M $148M -$20.5M $3.84 67
2023 Q3 43.2M $179M +$71.1M $4.15 64
2023 Q2 26.3M $127M -$5.26M $4.81 52
2023 Q1 27.8M $113M -$4.58M $4.06 61
2022 Q4 28.7M $155M -$5.37M $5.40 59
2022 Q3 27.5M $276M +$19.5M $10.03 48
2022 Q2 25.6M $120M -$6.03M $4.70 44
2022 Q1 27.1M $106M -$3.03M $3.91 53
2021 Q4 25.6M $173M -$1.67M $6.76 50
2021 Q3 24.1M $357M +$307M $14.86 40